Copyright
©The Author(s) 2022.
World J Hepatol. Sep 27, 2022; 14(9): 1704-1717
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1704
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1704
Group | Definition | Scoring |
Steatosis | < 5% | 0 |
5%-33% | 1 | |
> 33%-66% | 2 | |
> 66% | 3 | |
Lobular inflammation | No foci | 0 |
< 2 foci per 200× field | 1 | |
2-4 foci per 200× field | 2 | |
> 4 foci per 200× field | 3 | |
Hepatocyte ballooning | None | 0 |
Few | 1 | |
Many | 2 | |
Fibrosis | No fibrosis | 0 |
Zone 3 mild perisinusoidal fibrosis | 1a | |
Zone 3 moderate perisinusoidal fibrosis | 1b | |
Periportal/portal fibrosis only | 1c | |
Zone 3+ periportal/portal fibrosis | 2 | |
Bridging fibrosis | 3 | |
Cirrhosis | 4 |
- Citation: Mandour MO, El-Hassan M, Elkomi RM, Oben JA. Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future? World J Hepatol 2022; 14(9): 1704-1717
- URL: https://www.wjgnet.com/1948-5182/full/v14/i9/1704.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i9.1704